The American Thoracic Society improves global health by advancing research, patient care, and public health in pulmonary disease, critical illness, and sleep disorders. The RT team dives in to discuss some of the top storylines from the upcoming 2022 conference.
In the second in series of updates on guidance for infection control in acute-care hospitals, five medical organizations are recommending best practices for preventing hospital-associated pneumonia.
The first study to look at follow-up for patients deemed at high risk for lung cancer after CT screening found that 47% delayed follow-up care, according to research presented at ATS 2022.
The American Thoracic Society improves global health by advancing research, patient care, and public health in pulmonary disease, critical illness, and sleep disorders. The RT team dives in to discuss some of the top storylines from the upcoming 2022 conference.
One of the legacies of “redlining” may be higher incidence and mortality rates...
Johns Hopkins researchers have developed a protocol to reduce the number of pediatric ICU blood cultures that is likely to reduce antibiotic prescriptions without increasing the risk of sepsis.
The American Lung Association millennial lung study will track 4,000 young adults (aged 25-35) at the age of peak lung health for five years to evaluate how their environment, lifestyle, and physical activity habits affect respiratory health.
The health and economic impact of the Pfizer-BioNTech vaccine during its first year of rollout in the US is described in a new study in the peer-reviewed Journal of Medical Economics.
Clinicians agree that counseling patients on the potential effects of vaping and screening early with pulmonary function testing can reduce harm, but there is still a lot to learn about the health consequences of e-cigarettes.
Computational modeling shows that noninvasive respiratory support is more likely to be successful if it allows significant reductions in patients’ breathing efforts.
University of California, San Francisco, researchers are following volunteers who’ve recovered from COVID-19, collecting blood and saliva samples at regular intervals to monitor changes in antibody levels.
Researchers have successfully used bacteriophages – viruses that kill bacteria – to treat an antibiotic-resistant mycobacterial lung infection, clearing the way for a young patient with cystic fibrosis to receive a life-saving lung transplant.